ERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases
- PMID: 39362670
- PMCID: PMC11561405
- DOI: 10.1183/13993003.01257-2024
ERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases
Abstract
Epigenetic age is a novel biomarker utilising DNA methylation profiles that can detect accelerated biological ageing. Potential uses in respiratory disease include risk stratification for vulnerable patients and prognostication for poor clinical outcomes.
Conflict of interest statement
Conflict of interest: A.I. Hernandez Cordero reports grants from the Canadian Institutes of Health Research and payments to their institution for research from the BC Lung Foundation. J.M. Leung reports grants from the Canadian Institutes of Health Research and BC Lung Foundation (paid to institution, work outside of this manuscript), payment or honoraria for lectures, presentations, manuscript writing, or educational events from the BC Lung Foundation (payments for participation in COPD patient forums) and the University of British Columbia (payments for continuing medical education lectures), participation on data safety monitoring boards with Enhance Quality Safety, and Patient experience in Chronic Obstructive Pulmonary Disorder (EQuiP COPD) (no payments), and leadership or fiduciary roles with the Canadian Respiratory Research Network and CanCOLD Study as a member of the steering committee (no payments).
Figures

References
LinkOut - more resources
Full Text Sources